STERIALS

A biopharmaceutical company focused on developing and commercializing new drugs for diseases of the central nervous system. The company offers an injectable drug for adults used to manage acute pain severe enough to require intravenous administration of opioid painkillers and when no alternative treatment is available. The company is also developing drugs for the treatment of diabetic neuropathic pain, epilepsy, acute migraine headaches and opioid use disorder. The company is based in Delaware.